Literature DB >> 1532595

Acute VIth cranial nerve dysfunction in multiple sclerosis. Evaluation by magnetic resonance imaging.

J W Rose1, K B Digre, S G Lynch, R H Harnsberger.   

Abstract

VIth nerve palsy is not frequently considered a presenting sign of multiple sclerosis (MS); however, MS has been documented as a fairly common cause of VIth nerve dysfunction. In the present study we have evaluated the clinical features and magnetic resonance imaging (MRI) findings in four MS patients with acute VIth nerve palsy. Diplopia as a result of acute VIth nerve palsy was the prominent symptom leading to the diagnosis of MS in all of the individuals. Other signs specifically localizing to the ipsilateral brainstem were absent in these patients. Cranial MRI revealed multiple white matter lesions with a periventricular predominance in all four patients and pontine white matter lesions in three of the patients. These lesions were either adjacent to the VIth nerve nucleus or involved the fasciculus of the VIth nerve or both.

Entities:  

Mesh:

Year:  1992        PMID: 1532595

Source DB:  PubMed          Journal:  J Clin Neuroophthalmol        ISSN: 0272-846X


  4 in total

1.  Pontine lesions mimicking acute peripheral vestibulopathy.

Authors:  F Thömke; H C Hopf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

2.  Abduction paresis with rostral pontine and/or mesencephalic lesions: Pseudoabducens palsy and its relation to the so-called posterior internuclear ophthalmoplegia of Lutz.

Authors:  F Thömke; H C Hopf
Journal:  BMC Neurol       Date:  2001-12-18       Impact factor: 2.474

3.  More Than Meets the Eye: Isolated Bilateral Abducens Nerve Palsy as the Initial Presentation of Multiple Sclerosis.

Authors:  Pius E Ojemolon; Rebecca E Enejo; Endurance O Evbayekha; Livio U Ituah; Hafeez Shaka
Journal:  Cureus       Date:  2022-07-23

Review 4.  Multiple sclerosis.

Authors:  S G Lynch; J W Rose
Journal:  Dis Mon       Date:  1996-01       Impact factor: 3.800

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.